BRIEF-Astrazeneca Says AZD1222 Vaccine Can Be 90% Effective Against Covid-19

AstraZeneca PLC: * ASTRAZENECA PLC - AZD1222 VACCINE EFFECTIVE AGAINST COVID-19

* ASTRAZENECA - NO HOSPITALISATIONS OR SEVERE CASES OF COVID-19 IN PARTICIPANTS TREATED WITH AZD1222 * ASTRAZENECA - TWO DIFFERENT DOSING REGIMENS DEMONSTRATED EFFICACY WITH ONE SHOWING A BETTER PROFILE

* ASTRAZENECA - NO HOSPITALISATIONS OR SEVERE CASES OF COVID-19 IN PARTICIPANTS TREATED WITH AZD1222 * ASTRAZENECA - NO HOSPITALISATIONS OR SEVERE CASES OF COVID-19 IN PARTICIPANTS TREATED WITH AZD1222

* ASTRAZENECA - TWO DIFFERENT DOSING REGIMENS DEMONSTRATED EFFICACY WITH ONE SHOWING A BETTER PROFILE * ASTRAZENECA - AZD1222 VACCINE MET PRIMARY EFFICACY ENDPOINT IN PREVENTING COVID-19

* ASTRAZENECA - COMPANY IS MAKING RAPID PROGRESS IN MANUFACTURING WITH A CAPACITY OF UP TO 3 BILLION DOSES OF VACCINE IN 2021 ON A ROLLING BASIS * ASTRAZENECA - ASTRAZENECA WILL NOW IMMEDIATELY PREPARE REGULATORY SUBMISSION OF DATA TO AUTHORITIES AROUND WORLD

* ASTRAZENECA - WE'VE FOUND THAT ONE OF OUR DOSING REGIMENS MAY BE AROUND 90% EFFECTIVE * ASTRAZENECA - MAKING RAPID PROGRESS IN MANUFACTURING WITH A CAPACITY OF UP TO 3 BILLION DOSES OF VACCINE IN 2021 ON A ROLLING BASIS,

* ASTRAZENECA - IN PARALLEL, FULL ANALYSIS OF INTERIM RESULTS IS BEING SUBMITTED FOR PUBLICATION IN A PEER-REVIEWED JOURNAL * ASTRAZENECA - AZD1222 WAS WELL TOLERATED ACROSS BOTH DOSING REGIMENS.

* ASTRAZENECA - VACCINE'S EFFICACY AND SAFETY CONFIRM THAT IT WILL BE HIGHLY EFFECTIVE AGAINST COVID-19 * ASTRAZENECA - IN TOTAL, COMPANY EXPECTS TO ENROL UP TO 60,000 PARTICIPANTS GLOBALLY

* ASTRAZENECA - VACCINE'S SIMPLE SUPPLY CHAIN AND OUR NO-PROFIT PLEDGE AND COMMITMENT TO BROAD, EQUITABLE AND TIMELY ACCESS MEANS IT WILL BE AFFORDABLE * ASTRAZENECA - IN TOTAL, COMPANY EXPECTS TO ENROL UP TO 60,000 PARTICIPANTS GLOBALLY.

* ASTRAZENECA - COMPANY EXPECTS TO ENROL UP TO 60,000 PARTICIPANTS GLOBALLY. * ASTRAZENECA - VACCINE CAN BE STORED, TRANSPORTED, HANDLED AT NORMAL REFRIGERATED CONDITIONS (2-8 DEGREES CELSIUS/ 36-46 DEGREES FAHRENHEIT)

* ASTRAZENECA - VACCINE CAN BE STORED, TRANSPORTED, HANDLED AT NORMAL REFRIGERATED CONDITIONS FOR AT LEAST SIX MONTHS Source text for Eikon: Further company coverage: